Sam Fisher (Data Drops) – Telegram
Sam Fisher (Data Drops)
1.12K subscribers
7.31K photos
4.95K videos
10.9K files
12.4K links
All the files that're in my file archive, it's like the library, but not! (you can keep these and there's no fines!)
Download Telegram
Sam Fisher (Data Drops) pinned «Ukraine war: Serbia uproar over Wagner mercenaries recruiting for Russia More gearing up Serbia, as the next stage of the war perhaps? https://www.bbc.co.uk/news/world-europe-64329371»
Sam Fisher (Data Drops) pinned «800,000 Year-Old Queen Discovered In Egypt? Well this kinda screws things up for the mainstream time line of human history doesn't it? https://www.thearchaeologist.org/blog/800000-year-old-queen-discovered-in-egypt»
The HORRIFIC Torture Of The Stairs Of Death Of Mauthausen - The untold past

To say this was a tad barbaric, doesn't come close to cutting it!
Another example of why the obsession over gas Chambers, is all that, those that deny the Nazi's were psychopathic killers have... This kind of thing, is a little too problematic, even for them, so they'd rather sweep it under the rug!

https://youtu.be/ASFSY4-T7eo
Sam Fisher (Data Drops) pinned «EXTREMELY Brutal Crimes of Martin Sommer - Nazi Guard Too Cruel Even for Nazi Standards - Buchenwald Just like the above, the same can be said for this, unbearably lovely individual... https://youtu.be/ceixuthG96I»
Forwarded from Devin Devasquez
😁1
jiac317.pdf
833.4 KB
Oxford Journal of Infectious Diseases (January 2023 issue Drop 1 of 3)

In this first issue of the OJID for 2023, we have some very interesting studies to go over.
It looks like the mRNA shots, being reverse transcribed into your DNA, is finally beginning to be taken seriously by mainstream academia. There's also some interesting studies on the rise in RSV cases during the last 3 years and something I covered in my series on the Pfizer FOIA documents releases.

1) Sensitivity of Reverse Trannoscription Polymerase Chain Reaction Tests for SARSCov 2 Through Time

2) Memory B-Cell Development After Asymptomatic or Mild Symptomatic SARS-CoV-2 Infection

3) Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19

4) Potent Neutralizing Activity of Polyclonal Equine Antibodies Against SARS Cov 2 Variants of Concern

5) SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody- Mediated Immunity
🔥1